Treatment of complicated urinary tract infections with sisomicin a comparison of once daily and twice daily dosage forms

Infection ◽  
1976 ◽  
Vol 4 (S4) ◽  
pp. S498-S500 ◽  
Author(s):  
P. Madsen ◽  
T. Kjaer ◽  
A. Mosegaard
2019 ◽  
Vol 380 (8) ◽  
pp. 729-740 ◽  
Author(s):  
Florian M.E. Wagenlehner ◽  
Daniel J. Cloutier ◽  
Allison S. Komirenko ◽  
Deborah S. Cebrik ◽  
Kevin M. Krause ◽  
...  

2011 ◽  
Vol 16 (2) ◽  
pp. 102-107
Author(s):  
Donna Huynh ◽  
Jill A. Morgan

ABSTRACT This case report describes the use of intravesicular amikacin irrigations to treat and prevent urinary tract infections (UTIs) in a pediatric patient with spina bifida and neurogenic bladder. A 15 year old Hispanic female was admitted for a UTI caused by Enterobacter cloacae and multiple-drug resistant Pseudomonas aeruginosa. A 7 day course of daily intravenous amikacin and ceftazidime was initiated along with twice daily intravesicular amikacin irrigations (15 mg/30 mL) with a dwell time of 2 hours. The patient improved and was discharged on prophylactic Bactrim SS (sulfamethoxazole/trimethoprim) 1 tablet daily and intravesicular amikacin irrigations (15 mg/30 mL) once every other day. Approximately 2 months after discharge, the patient developed another UTI from multidrug resistant Escherichia coli and was treated with a 14 day course of daily intravenous ciprofloxacin accompanied by daily intravesicular amikacin irrigations. Adjunctive therapy with either once daily or twice daily intravesicular amikacin irrigations successfully treated the patient's UTI. However, prophylactic treatment with intravesicular amikacin failed to prevent future UTIs in this patient.


Sign in / Sign up

Export Citation Format

Share Document